Use the search to find what you are looking for
An editorial in this week’s Lancet Oncology is worth reading before we get too carried away, without evidence, of what immunotherapy might do for CUP patients. The concluding paragraph begins: ‘While heralding an enticing treatment opportunity, it is essential to bear in mind that the current generation of immunotherapies merely extends life expectancy for a small proportion of patients.’